openPR Logo
Press release

Botulinum Toxin Market Key Companies – Allergan, Eisai Co., Ltd., Galderma S.A., Hugel Inc., Hugh source international ltd., Ipsen, Medytox Inc., Merz Pharma and Revance Therapeutics, Inc.

09-30-2019 01:59 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Botulinum Toxin Market Trends Statistics 2019 | Growth Projection 2025

Botulinum Toxin Market Trends Statistics 2019 | Growth Projection 2025

Increasing demand among patients for nonsurgical cosmetic treatments has proliferated global botulinum toxin market, along with the prevalence of numerous medical conditions like migraine headaches and excessive sweating. In recent times, the awareness about botulinum toxin and its various benefits have increased due to the extensive adoption of botulinum toxin therapies by dermatologists for reducing signs of aging as well as eliminating facial lines and wrinkles in people.

Out of the two key subtypes, botulinum toxin A is the considered as one of the most potent and has gained rapid and enthusiastic acceptance amid customers. It is now being used clinically with most frequently performed procedures, helping millions to rejuvenate their physical appearance. Botox A will undoubtedly represent a prominent growth segment for botulinum toxin industry players, with beauty salons and spas also providing injectable Botox treatments. Growing trend among middle-aged women to stay young and attractive will subsequently boost botulinum toxin market expansion.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/3408

According to the America Society of Plastic Surgeons, Botox treatment is the most prevalent cosmetic medical procedure in the US, with around 7.23 million procedures reportedly performed in 2017. Botulinum toxin A was initially approved by the U.S. FDA for treating crossed eyes and in the year 2002, it was approved for cosmetic treatment. Botulinum toxin market has gained traction in US specifically on the account of treating dermatologic conditions including crow’s feet near the eyes, thick jaw muscles and gummy smiles, achieving optimal results globally and advancing the industry scope.

Besides cosmetic therapies, botulinum toxin has become a safe and effective therapeutic tool for a wide range of medical conditions including chronic migraines, muscle spasticity, and dysphonia. Apparently, in 2010 it was approved by the U.S. Food and Drug Administration (FDA) for the prevention of chronic migraines. Migraines are the third most common disorder globally, with an estimated worldwide prevalence of 14.7%. Botox injections provide one of the most effective and positive treatments and a prominent study reveals that most people experience reduction in migraine frequency. This will create substantial product demand for botulinum toxin industry, as chronic diseases are leading causes of fatality in people of all ages.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/3408

Allergan plc had announced the results of higher doses of its Botox Cosmetic product in 2018 for the treatment of moderate to severe glabellar lines. This trial was significantly helpful in evaluating the duration of effect and safety of the treatment. Such trials indicate the application scope of botulinum toxin market. Allergan had also unveiled 29 presentations including 24 migraine presentations highlighting the company’s innovations for addressing migraine problems. Undoubtedly, innovations and product-driven approaches would pave the way for botulinum toxin industry towards depicting an upward revenue graph in the next few years.

Rising geriatric population around the globe has created opportunities for the application of botulinum toxin in the treatment of spasticity, which causes specific body muscles to be continuously contracted. The disease affects nearly 12 million people worldwide, while 80% of multiple sclerosis patients suffer from varying levels of spasticity. Common occurrence of disorders that cause spasticity, such as strokes, traumatic brain injuries and meningitis will warrant a considerable demand for effective therapies. Oral as well as injected botulinum toxin are considered to be helpful in dealing with cerebral palsy spasticity, reinforcing the market penetration.

With the healthcare sector experiencing significantly higher consumption than before and the surge in preference for nonsurgical cosmetic treatments, botulinum toxin industry is projected to amass tremendous revenues worldwide. Escalating competition among major industry players by executing mergers & acquisitions and innovating transformative therapies will underscore the industry dynamics imminently. Reports suggest that global botulinum toxin market size is anticipated to exceed USD 8.5 billion by 2025.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Botulinum Toxin Market Key Companies – Allergan, Eisai Co., Ltd., Galderma S.A., Hugel Inc., Hugh source international ltd., Ipsen, Medytox Inc., Merz Pharma and Revance Therapeutics, Inc. here

News-ID: 1841151 • Views: 458

More Releases from Global Market Insights, Inc.

Europe Electrical Steel Market Projections – To Expand at 6.5% During 2019-202 …
According to a new research report by Global Market Insights, Inc. Electrical Steel Market size is set to surpass USD 22.5 billion by 2025. Expansion of power distribution networks, increasing energy demand and rising preference for higher speed and horsepower to enable racecars to perform efficiently will further stimulate electrical steel market size in the future. Increase in the per capita income and surging government regulations for the transformer used
Shape Memory Alloys Market
Asia-Pacific Shape Memory Alloys Market will witness over 14% CAGR up to 2025.Rising disposable income among people especially in emerging nations such as China, India, and Japan, has propelled shape memory alloys (SMA) market, owing to increased demand for automobiles and home appliances. China is regarded as the leading automobile manufacturer in the world and accounted for one-fourth of the global automobile production in the year 2018. During the same
America SLI Battery Market Analysis 2019-2025 With Top Companies of Industry lik …
Eminent market participants across America SLI battery market comprise of Grupo Gonher, Johnson Controls, Continental Battery, Exide Technologies, U.S. Battery, East Penn, XS Power battery, Enersys, Dyno Battery, Crown Battery, ACDelco, Leoch International, Braille Battery, Trojan Battery Company, Discover Battery, Acumuladores Moura, NorthStar Battery, Power Sonic, Interstate Batteries and GS Yuasa. Global Market Insights, Inc., announces a report on America SLI Battery Market Trends & Forecast - 2025.' The study encompasses
Natural Gas Liquid Market Analysis 2019-2025 :BP, Petrobras, Royal Dutch Shell, …
Eminent industry players operating across the natural gas liquid market comprises of BP, Petrobras, Royal Dutch Shell, Exxon, Qatar Petroleum, Canadian Natural Resources, Range Resources, Rosneft, Riveria, Eni, ConocoPhilips, Equinor, Total, Gazprom, Lukoil, Devon, and Chevron. Japan NGL market is set to exceed the consumption of 0.2 mbl/day by 2025. Growing demand for high value-added manufactured petrochemicals coupled with accelerating investments toward chemical industry will propel the industry growth. Furthermore, rapidly

All 5 Releases


More Releases for Botulinum

Global Botulinum Neurotoxins Market Research Report
This report studies the global Botulinum Neurotoxins market status and forecast, categorizes the global Botulinum Neurotoxins market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Johnson & Johnson GSK Allergan Chong Kun Dang Eisai Nestle Galderma Ipsen Hugel Mentor CROMA Alphaeon OBI
Botulinum Toxin Market: Adoption of Non-Surgical Botulinum Toxin to Favor Growth …
The botulinum toxin market growth is strongly underpinned by rising investment towards the development of novel therapeutic applications of botulinum toxin. Additionally, surged cosmetic expenditure owing to elevated disposable income across regions further widen growth scope. However, prevalence of various side effects coupled with high pricing are likely to stunt market growth significantly. Market Research Hub (MRH) has recently added a new business intelligence report titled, ‘Botulinum Toxin Market - Global
Botulinum Toxin Market - Global Industry Insights, 2026
Botulinum toxin is a product produced by naturally occurring Clostridium botulinum bacteria. This bacteria is found in soil and marine sediments and can produce harmful neurotoxin botulinum toxin. Botulinum toxin is a ‘blocking agent’ which inhibits the release of certain neurotransmitters, specifically acetylcholine, from the endings of the motor nerves. There are about eight types of botulinum toxin named from type A to H. Botulinum toxin type A and botulinum
Botulinum Toxin Market highly efficient technology developed by 2025
Global Botulinum Toxin Market: Snapshot Botulinum toxin, known to the mankind as one of the most poisonous biological substances, is a neurotoxin produced by the Clostridium botulinum bacteria. Clostridium botulinum, the gram-positive, anaerobic, spore-forming bacteria commonly found in water, soil, on plants, and the intestinal tracts of animals can be elaborated into eight exotoxins, all interfering with the process of neural transmission and causing muscle paralysis. From the earliest recorded uses of
Botulinum Toxin Market - Regional Outlook, Segments And Forecast To 2025
Global Botulinum Toxin Market: Snapshot Botulinum toxin, known to the mankind as one of the most poisonous biological substances, is a neurotoxin produced by the Clostridium botulinum bacteria. Clostridium botulinum, the gram-positive, anaerobic, spore-forming bacteria commonly found in water, soil, on plants, and the intestinal tracts of animals can be elaborated into eight exotoxins, all interfering with the process of neural transmission and causing muscle paralysis. From the earliest recorded uses of
Botulinum Toxin Market - Industry Analysis,Trends and Forecast 2017 - 2025
Global Botulinum Toxin Market: Snapshot Botulinum toxin, known to the mankind as one of the most poisonous biological substances, is a neurotoxin produced by the Clostridium botulinum bacteria. Clostridium botulinum, the gram-positive, anaerobic, spore-forming bacteria commonly found in water, soil, on plants, and the intestinal tracts of animals can be elaborated into eight exotoxins, all interfering with the process of neural transmission and causing muscle paralysis. From the earliest recorded uses of